• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性血友病患者的血友病性关节病。

Hemophilic arthropathy in patients with von Willebrand disease.

机构信息

Department of Haematology/Van Creveldkliniek, University Medical Center Utrecht, The Netherlands.

出版信息

Blood Rev. 2012 Nov;26(6):261-6. doi: 10.1016/j.blre.2012.09.002. Epub 2012 Sep 23.

DOI:10.1016/j.blre.2012.09.002
PMID:23010260
Abstract

von Willebrand disease (VWD) affects approximately 1% of the population. Joint bleeds are not a predominant symptom of VWD, however they do occur. Especially in patients with severe VWD, joint bleeds have been described in up to 45% of the patients. Recurrent hemarthroses can lead to joint destruction which is the main cause of morbidity, as is observed in hemophilia patients. In VWD however, the occurrence, severity, onset, treatment and impact of arthropathy have not been well described. This literature review summarizes all publications on arthropathy in patients with hereditary VWD, published until 1-5-2012. Joint bleeds in VWD are associated with low FVIII levels and seem to occur at young age. Depending on the severity of VWD, arthropathy occurs in 2-30% of the patients. Radiological joint damage can be seen but has not systematically been studied. Arthropathy can affect daily functioning and interfere with the quality of life. For acute management of joint bleeds FVIII/VWF concentrates can be used in VWD patients unresponsive to desmopressin or desmopressin in responsive VWD patients. When severe joint bleeds have caused synovitis and arthropathy, chemical or radioactive synovectomy and surgical joint procedures seem feasible to prevent further joint damage. Additional research is needed to learn more about the severity, onset and impact of arthropathy in VWD. Ongoing studies will hopefully answer the question whether prophylactic treatment with coagulation factor concentrates should be considered standard of care in severe VWD to prevent arthropathy.

摘要

血管性血友病(VWD)影响大约 1%的人口。关节出血并不是 VWD 的主要症状,但确实会发生。尤其是在严重 VWD 的患者中,高达 45%的患者出现过关节出血。反复发生的关节积血可导致关节破坏,这是导致发病率的主要原因,就像血友病患者一样。然而,在 VWD 中,关节病的发生、严重程度、发病、治疗和影响尚未得到很好的描述。这篇文献综述总结了截至 2012 年 5 月 1 日发表的所有关于遗传性 VWD 患者关节病的出版物。VWD 中的关节出血与 FVIII 水平低有关,似乎发生在年轻时期。根据 VWD 的严重程度,2-30%的患者会发生关节病。可以看到放射学关节损伤,但尚未进行系统研究。关节病会影响日常功能,并干扰生活质量。对于急性关节出血的管理,FVIII/VWF 浓缩物可用于对去氨加压素无反应或对去氨加压素有反应的 VWD 患者。当严重的关节出血引起滑膜炎和关节病时,化学或放射性滑膜切除术以及手术关节程序似乎可以预防进一步的关节损伤。需要进一步的研究来了解 VWD 中关节病的严重程度、发病和影响。正在进行的研究有望回答是否应考虑在严重 VWD 中预防性使用凝血因子浓缩物作为预防关节病的标准治疗方法。

相似文献

1
Hemophilic arthropathy in patients with von Willebrand disease.血管性血友病患者的血友病性关节病。
Blood Rev. 2012 Nov;26(6):261-6. doi: 10.1016/j.blre.2012.09.002. Epub 2012 Sep 23.
2
Prophylaxis and von Willebrand's disease (vWD).预防与血管性血友病(vWD)
Thromb Res. 2006;118 Suppl 1:S3-7. doi: 10.1016/j.thromres.2006.01.014. Epub 2006 Mar 31.
3
Prophylaxis in von Willebrand disease.血管性血友病的预防
Haemophilia. 2008 Nov;14 Suppl 5:47-53. doi: 10.1111/j.1365-2516.2008.01851.x.
4
Long-term impact of joint bleeds in von Willebrand disease: a nested case-control study.血管性血友病患者关节出血的长期影响:一项巢式病例对照研究。
Haematologica. 2017 Sep;102(9):1486-1493. doi: 10.3324/haematol.2017.168617. Epub 2017 Jun 1.
5
Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.3型血管性血友病出血并发症的预防和治疗
Semin Thromb Hemost. 2006 Sep;32(6):621-5. doi: 10.1055/s-2006-949667.
6
Orthopaedic surgery in patients with von Willebrand disease.骨科手术治疗 von Willebrand 病患者。
Haemophilia. 2014 Jan;20(1):133-40. doi: 10.1111/hae.12258. Epub 2013 Aug 28.
7
Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study.血管性血友病患者的关节出血对生活质量和关节完整性有重大影响:一项横断面研究。
Haemophilia. 2015 May;21(3):e185-e192. doi: 10.1111/hae.12670. Epub 2015 Apr 9.
8
The von Willebrand disease prophylaxis network (vWD PN): exploring a treatment concept.血管性血友病预防网络(vWD PN):探索一种治疗理念。
Thromb Res. 2006;118 Suppl 1:S19-22. doi: 10.1016/j.thromres.2006.01.016. Epub 2006 Mar 20.
9
Clinical experience of prophylactic treatment in von Willebrand disease.血管性血友病预防性治疗的临床经验
Thromb Res. 2006;118 Suppl 1:S9-11. doi: 10.1016/j.thromres.2006.01.021. Epub 2006 Apr 17.
10
Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.静脉注射去氨加压素和因子VIII-血管性血友病因子浓缩物用于治疗和预防1型、2型和3型血管性血友病患者的出血。
Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399.

引用本文的文献

1
Bilateral total knee replacement for hemophilic arthropathy: a case report.血友病性关节病的双侧全膝关节置换术:一例报告
BMC Musculoskelet Disord. 2025 Apr 25;26(1):417. doi: 10.1186/s12891-025-08611-1.
2
DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis.去氨加压素反应及其在出血性疾病中的决定因素:一项系统评价和荟萃分析。
Blood. 2025 Apr 17;145(16):1814-1825. doi: 10.1182/blood.2024026804.
3
Genetic insights and therapeutic avenues: unraveling the role of polyunsaturated fatty acids as mediators between hypothyroidism and Von Willebrand disease through Mendelian randomization.
遗传学见解与治疗途径:通过孟德尔随机化揭示多不饱和脂肪酸在甲状腺功能减退症与血管性血友病之间作为介质的作用。
Front Genet. 2025 Jan 8;15:1426401. doi: 10.3389/fgene.2024.1426401. eCollection 2024.
4
Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies.应对挑战:一例关于管理伴有同种抗体的3型血管性血友病复杂产后病程的病例报告
Res Pract Thromb Haemost. 2024 Apr 3;8(3):102399. doi: 10.1016/j.rpth.2024.102399. eCollection 2024 Mar.
5
Ultrasound in addition to clinical assessment of acute musculoskeletal complaints in bleeding disorders: impact on patient management.除临床评估外,超声在出血性疾病急性肌肉骨骼疾病中的应用:对患者管理的影响
Res Pract Thromb Haemost. 2024 Mar 15;8(2):102372. doi: 10.1016/j.rpth.2024.102372. eCollection 2024 Feb.
6
Quantitative MRI assessment of joint effusion using T2-relaxometry at 3 Tesla: a feasibility and reproducibility study.3T 下 T2 弛豫测量法评估关节积液的定量 MRI:一项可行性和可重复性研究。
Skeletal Radiol. 2024 Nov;53(11):2389-2398. doi: 10.1007/s00256-024-04652-0. Epub 2024 Mar 21.
7
Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report.1例因复发性膝关节积血导致慢性滑膜炎的获得性血管性血友病综合征患者成功进行化学性滑膜切除:病例报告
Rheumatol Ther. 2022 Oct;9(5):1465-1474. doi: 10.1007/s40744-022-00477-2. Epub 2022 Aug 10.
8
Patient-reported outcomes in autosomal inherited bleeding disorders: A systematic literature review.常染色体遗传性出血性疾病患者报告结局的系统文献回顾。
Haemophilia. 2022 Mar;28(2):197-214. doi: 10.1111/hae.14492. Epub 2022 Jan 18.
9
Von Willebrand Disease: Current Status of Diagnosis and Management.血管性血友病:诊断与管理的现状。
Hematol Oncol Clin North Am. 2021 Dec;35(6):1085-1101. doi: 10.1016/j.hoc.2021.07.004. Epub 2021 Aug 13.
10
New developments in von Willebrand disease.血管性血友病的新进展。
Br J Haematol. 2020 Nov;191(3):329-339. doi: 10.1111/bjh.16681. Epub 2020 May 12.